Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market.

Eli Lilly (LLY) is targeting additional drug compounders and telehealth companies that make copycat versions of its ... Novo Nordisk (NVO) markets Ozempic and Wegovy injections, while Hims ...

Saxenda (liraglutide) and Ozempic (semaglutide) are brand-name solutions for subcutaneous injection. Saxenda is approved for weight management. Doctors may prescribe Ozempic off-label for this ...

Ozempic is an injectable medication primarily used for type 2 diabetes but due to weight loss being a side effect, many have misused the prescription drug in their quests to shed a few pounds.

Supply issues finally started to ease late in 2024, as compounded semaglutide — "copycats ... semaglutide at a price of $165 a month — compared to $1,799 a month for Ozempic, and a whopping ...

Supply issues finally started to ease late in 2024, as compounded semaglutide — "copycats" of the patented ... offers compounded semaglutide at a price of $165 a month — compared to $1,799 a month for ...